Global Breast Cancer Therapeutics Market 2019-2023 | Rise in Strategic Collaborations to Boost Growth | Technavio
LONDON--(BUSINESS WIRE)--Dec 26, 2018--The global breast cancer therapeutics market is expected to post a CAGR of close to 8% during the period 2019-2023, according to the latest market research report by .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181226005053/en/
Technavio has published a new market research report on the global breast cancer therapeutics market from 2019-2023. (Graphic: Business Wire)
A key factor driving the growth of the global breast cancer therapeutics market is the robust pipeline and new drug approvals. The global market is witnessing the emergence of several novel therapies with the therapeutic potential to address advanced stages of breast cancer.
This market research report on the also provides an analysis of the most important trends expected to impact the market outlook during the forecast period.
Global breast cancer therapeutics market: Rise in strategic collaborations
Over the past few years, the global breast cancer therapeutics market has been witnessing an increase in the number of collaborations and acquisitions among research groups, manufacturers, and government bodies. Several leading manufacturers are acquiring therapies from other vendors through collaborations that are worth billions to develop an ideal therapeutic approach for the treatment of breast cancer.
“Breast cancer is the most frequently diagnosed cancer in women globally. Some of the risk factors for breast cancer include BRCA1 or BRCA2 mutations, abnormal breast biopsy, dense breast density, alcohol consumption among others. These risk factors are attributable to the rising prevalence of breast cancer, which is the major factor driving the global breast cancer therapeutics market,” says a senior analyst at Technavio for research on pharmaceuticals, biotechnology & life sciences.
Global breast cancer therapeutics market: Segmentation analysis
This market research report segments the global breast cancer therapeutics market by product (targeted therapy, hormonal therapy, and chemotherapy), and geographical regions (APAC, EMEA, and the Americas).
The Americas region led the market in 2018 with a market share of close to 45%, followed by EMEA and APAC respectively. The Americas region will continue to dominate the market with the highest incremental growth during the forecast period.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181226005053/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: WOMEN HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL CONSUMER
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 12/26/2018 09:40 AM/DISC: 12/26/2018 09:40 AM